The following items can be checked out from The Flippin Lyme Foundation for free. The request form is at the bottom of this page.
Under Our Skin DVD
Under Our Skin 2: Emergence
Pioneers: Healing Lyme with Bee Venom Therapy & Workbook
How Can I Get Better?
Richard Horowitz LLMD
See on Amazon
Insights Into Lyme Disease Treatment
The Paleo Approach - Reverse Autoimmune Disease and Heal Your Body
Sarah Ballantyne, PhD
The Beekeeper's Handbook (4th edition)
Diana Sammataro, Alphonse Avitabile
by Dietrich K. Klinghardt, M.D., Ph.D.
Lyme disease has become, after AIDS, probably the fastest spreading infectious disease. "Classical" Lyme disease is a bacterial infection caused by a spirochete, Borrelia burgdorferi, which is passed to the patient by a tick bite. Since several other infections that cause similar symptoms can be transmitted by the same tick bite, and other infectious agents not transmitted by a tick can cause similar symptoms, the term "New Lyme Disease" is used by most holistic physicians. Lyme disease is not only a frequent underlying causal factor in chronic human illness, but also extremely common in pets, especially in dogs and horses.
The following microorganisms have to be considered when making the diagnosis of "New Lyme Disease."
The following symptoms can be caused by Lyme disease:
Until recently laboratory testing has been unsatisfactory with a detection rate of probably below 30%. In the past it was believed the laboratory evaluation of the spinal fluid was a reliable way to confirm or refute the diagnosis of Lyme disease. This has been proven wrong. The test with the broadest detection rate, the Western Blot ELISA test, has low specificity. The test with the highest specificity but with a fairly low detection rate was the PCR test. The B. burgdorferi is a master at evading the body's immune system and evading laboratory detection by modulating and changing its surface antigens. It can form a cystic stage, which is resistant to antibiotics, evades laboratory detection, and gives birth to healthy spirochetes once the antibiotics are discontinued.
A new test has become available recently: the C6 Lyme Peptide ELISA test (BBI Clinical Laboratories, Tel.: 1-800-866-6254 or 860-225-1900, test code: 556 - C6LPE. The test is based on the discovery of six peptides on the surface of the spirochete, which are consistently present and do not evade detection by the laboratory as many of the other surface antigens of B. burgdorferi do. This test detects all B. burgdorferi strains and genospecies. It is highly specific and more sensitive than conventional tests for chronic Lyme disease. It is also sensitive in early Lyme disease (which used to be problematic) and can be used for accurate antibody results for Lyme vaccinated patients.
Treatment has often been unsatisfactory in spite of correct diagnosis. Multiple antibiotic regimes have been tried with varying successes. The cystic stage responds only to one antibiotic: metronidazole (Flagyl). This drug should be given intravenously. The oral version is less effective and hard on the liver. It should always be given together with the herb "milk thistle" because of its liver-protective effect. A less toxic alternative is tinidazole, a Flagyl-derivative that is available in compounding pharmacies.
I use proteolytic enzymes for the purpose of breaking up the cyst wall and making the dormant form of B. burgdorferi inside the cyst vulnerable to both the host's immune system and the medications given for treatment.
Dosage: Wobenzyme, 8-10 tablets three times/day between meals and first thing a.m.
Treatment protocols using antibiotics are outlined in the website of J. Borrescano, MD: www.lymenet.com. I use, in selected cases, a combination of azithromycin or clarithromycin 250-500 mg two times/day in combination with trimethoprim 100 mg twice/day for 6-8 weeks.
My preferred treatment is a combination of enzymes, herbs, specific transfer factors and the injection of honeybee venom.
I follow the recommendations of Dr. Zhang, MD, LAc of New York (http://www.dr-zhang.com). His special garlic extract with a high concentration of Allicin:
2 mg Allicin/kg of bodyweight per day for 6 months; HH (Houttuyniae Herba): 3 tablets three times/day for 6 months.
His special Artemesia (wormwood) combination: 1-2 tablets three times/day for 6 months (usually recommended when Babesia is involved).
In addition I use the specific herbal combinations from the Monastery of Herbs in Los Angeles (Tel.: 818-360-4871). These are very effective 18-day programs. I use Autonomic Response Testing to determine the most effective combination. I rotate different regimes over the 6-month treatment period.
Specific Transfer Factors
When a pregnant cow is infected with a certain illness, her first milk (colostrum) after the calf is born contains specific peptides that prevent the illness in the calf. Based on this principle, specific transfer factors have become available for the treatment of B. burgdorferi, Babesia, Mycoplasma pneumoniae etc. Most readily available are oral capsules with dried peptide extracts (Chisolm Biological Laboratory, Tel.: 803-663 9618 / ext. 9777). By adding the specific transfer factors into the treatment regime, the success rate can be dramatically increased.
The pain relieving effect of bee venom in the treatment of clinical conditions similar to Lyme disease has been established a long time ago. Bee venom contains a number of potent peptides which are responsible for its healing effect ("Bee Venom Therapy for Chronic Pain," Dietrich Klinghardt, J. of Neurol and Orthop. Med and Surg., Vol. 11, Issue 9, Oct 1990, pp. 195-197). Recent research proved that one of the peptides in bee venom, melittin, has a strong inhibitory effect on the Lyme spirochete at very low doses ("Bee Stings as Lyme Inhibitor" by L. L. Lubke and C. F. Garon, J. Clin. Infect. Diseases, July 1997, 25 Suppl. 1, pp. 48-51). When the spirochete is inhibited it does not multiply and is vulnerable to the host's own immune system and to medication.
The dosage and frequency of treatment is determined by the patient's clinical response. Patients with Babesia or Mycoplasma infections require higher dosages then those with only B. burgdorferi infections.
Different bee venoms are on the market. I use the product VeneX, which comes in two different strengths: VeneX-10 and VeneX-20 (Table 1.). VeneX-20 is twice as concentrated as VeneX-10. VeneX-10 contains 1.0 mg of bee venom per 1.0 ml. A 0.1 ml of this solution delivers approximately the same amount of bee venom as a natural bee sting. The content of melittin in bee venom is dependent on where it is collected on the hive; the season and the pollen source the bees have access to at the time. Generally between one third and one half of the venom is melittin. Because of these variables the symptoms seen on administration of the venom can also vary. Bee venom is used for desensitization and is approved with the FDA for this purpose. There is an official monograph in the Homeopathic Pharmacopoea of the United States (HPUS), also recognized by the FDA.
Table 1. Comparison of Venom Solutions.
Vial Size (ml)
* Dried Venom Sac Equivalent (DVSE): 0.1 mg bee venom
The average maintenance dosage is 1.0 ml of VeneX-10 (or 0.5 ml of VeneX-20) mixed with 2.0 ml preservative free buffered procaine (available from ApotheCure in Dallas, TX) injected subcutaneously, given between one and three times weekly for 6-12 months. Even though much of the venom's effect is systemic, independent of the location where it is given, additional benefits are observed by injecting the venom in specific target areas.
These areas include:
Distribute the 2.5-3.0 ml bee venom and procaine mix over 10 areas, using 0.25 ml to 0.3 ml per injection. The injection is given with a 30g needle. The needle is advanced just deep enough for the needle tip to barely reach beyond the sensory skin nerves. If it burns, the needle is not deep enough. If it never burns, most likely the injections are given too deep, where the medication will be quickly flushed away by the blood stream and lymphatics, without having the much-desired local effect. For a long needle this means that the needle is inserted into the skin less than half way.
These injections should be painless and well tolerated. There is a welling up, itchiness and aching after 10 minutes or so, which becomes less with an increasing number of treatments. The discomfort may increase during the first four or five treatments and then lessen over time. The initial response determines the treatment frequency. The first injection often triggers an increase in well being and a decrease of pain levels after a few hours; sometimes as late as 24 hours after the injection. The initial improvement may last between 12 hours and several days. This determines if the patient needs to be treated once a day or as little as once a week. If the improvement is less than desired a higher dose of bee venom may be needed.
I start with a low initial dose of 0.3 ml VeneX-10 or 0.15 ml VeneX-20 to ride out the often strong initial reactions. Over the next treatments I increase the dose, depending on the response, rather rapidly to the full treatment dose (Table 2. and Table 3.). It is wise to wait with injecting around the head until the patient no longer has strong local reactions (redness, swelling).
Table 2. VeneX-10 and Procaine Calculation Table.
Injection / Dose
3 x 0.3 ml
5 x 0.3 ml
7 x 0.3 ml
4th and ...
10 x 0.3 ml
Dried Venom Sac Equivalent (DVSE): 0.1 mg bee venom
Table 3. VeneX-20 and Procaine Calculation Table.
Injection / Dose
3 x 0.25 ml
5 x 0.25 ml
7 x 0.25 ml
4th and ...
10 x 0.25 ml
* Dried Venom Sac Equivalent (DVSE): 0.1 mg bee venom
We have taught many patients to treat themselves with this procedure. It is far less painful than the use of live bees. However, treatment with live bees does not involve the use of technical supplies and is often the only practical alternative.
If live bees are used I recommend reading the textbook by Charles Mraz and the other literature supplied by Apitronic Services (Tel.: 604-271-9414). I also recommend using the Multi Treatment Mesh (MTM) or SoftSting devices by the same company that allows the bee to not loose its stinger, survive the procedure and return to its hive.
Caution: Everyone who uses bee venom on domestic animals or humans must have an Anakit, Epipen or other medically approved "bee-sting kit," within immediate reach. The Anakit contains a pre-drawn syringe with epinephrine, an oral antihistamine and instruction sheet. The Epipen contains epinephrine in a self-injecting form.
Recommendation: should the patient experience a systemic reaction (usually within minutes) with airway restriction, I recommend to inject one third (1/3rd) of the epinephrine subcutaneously into the palmar (soft) side of the forearm (same depth as the bee venom injection). The wheezing will stop at the price of an agitated feeling in the patient. Now he/she should take the antihistamine (swallow the pill), which takes 15-20 minutes to work. During this time, a second injection with epinephrine may be needed. In 20 years of using bee venom, I never needed to use this procedure. However, I have always combined bee venom with procaine, which prevents most allergic reactions.
Clinical observations: many cases of chronic fatigue, MS, ALS, memory loss, jaw problems, etc. are really undiagnosed Lyme disease. With the new Lyme laboratory test many of these cases can be appropriately diagnosed. The treatment outlined here is in my experience very gentle and yet the most successful approach.
Acupuncture charts -- Apitronic Services, Tel.: 604-271-9414
Dried peptide extracts -- Chisolm Biological Laboratory, Tel.: 803-663-9618 / ext. 9777
Herbs -- Monastery of Herbs, Los Angeles, Tel.: 818-360 4871
Herbs protocol -- Dr. Zhang, MD, LAc of New York, web site: www.dr-zhang.com
Lab test -- C6 Lyme Peptide ELISA test -- BBI Clinical Laboratories, test code: 556 - C6LPE, Tel.: 1-800-866-6254 or 860-225 1900
Multi Treatment Mesh (MTM) or SoftSting -- Apitronic Services, Tel.: 604-271-9414
Neural Therapy and Autonomic Response Testing workshops and resources -- American Academy of Neural Therapy, Inc., (AANT) 410 East Denny Way, Suite 18, Seattle, WA, USA, Tel.: 206-749-9967, Fax: 206-723-1367, E-mail: email@example.com, Web Site:
Procaine (preservative free) -- ApotheCure Pharmacy, Tel.: 1-800-969-6601
VeneX-10 and VeneX-20 -- Tel.: 604-271-9414
RESOURCES FOR INFORMATION
Books, Booklets and Literature
Beck, B. F., MD (1997) The Bible of Bee Venom Therapy. Health Resources Press, Inc., Silver Spring, MD, USA, book, ISBN 1-890708-03, pp. 238. Reprint of the original 1935 edition of Dr. Beck: Bee Venom Therapy - Bee Venom, Its Nature, and Its effect on Arthritic and Rheumatoid Conditions. (available from Apitronic Services: Tel.: 604-271-9414)
Broadman, J., MD (1997) Bee Venom - The Natural Curative for Arthritis and Rheumatism. Health Resources Press, Silver Spring, MD, USA, book, ISBN 1-890708-01-3, references, index, glossary, foreword by Harold Goodman, DO, pp. 224 (available from Apitronic Services: Tel.: 604-271-9414)
Klinghardt, D. K., MD (1990) Bee Venom Therapy for Chronic Pain. The Journal of Neurological & Orthopedic Medicine & Surgery, Vol. 11, No. 3, pp. 195-197
Klinghardt, Dietrich, MD (1999) Treatment Protocol for Bee Venom Therapy. Apitherapy Education Service - Apitronic Services, Richmond, BC, Canada, booklet, 11 pp.
Lubke, L. L. and Garon, C. F. (1997) Bee Stings as Lyme Inhibitor. J. Clin. Infect. Diseases, July, 25 Suppl. 1, pp. 48-51
Marinelli, Rick, ND and Klinghardt, Dietrich, MD (1999) Methodology for Injectable Bee Venom Therapy. Apitherapy Education Service - Apitronic Services, Richmond, BC Canada, 12 pp.
Mraz, Charles (1994) Health and the Honeybee. Queen City Publications, Burlington, VT, USA, ISBN 0-9642485-0-6, pp. vii+92 (available from Apitronic Services: Tel.: 604-271-9414)
American Apitherapy Society, Inc., 5390 Grande Rd., Hillsboro, OH 45133 USA, Tel.: 937-364-1108, Fax: (937) 364-9109, e-mail: firstname.lastname@example.org, web page: www.apitherapy.org/aas
American Academy of Neural Therapy, Inc., 410 East Denny Way, Suite 18, Seattle, 98122 USA, Tel.: 206-749-9967, Fax: 206-723-1367, e-mail: email@example.com, web page:
American Academy of Neural Therapy, Inc.
Bee Venom Therapy Supplies and Books
Apitherapy Reference Database
Bee Venom Therapy Supplies and Books Bee venom products and therapy related books, literature and Apitherapy Education Service.
9611 No. 4 Road
Canada, V7A 2Z1
Conversion Table 0.10 ml = 0.10 cc0.60 ml = 0.60 cc 0.20 ml = 0.20 cc0.70 ml = 0.70 cc 0.30 ml = 0.30 cc0.80 ml = 0.80 cc 0.40 ml = 0.40 cc0.90 ml = 0.90 cc 0.50 ml = 0.50 cc1.00 ml = 1.00 cc
Scientists have tracked the syndromes associated with aging to their biochemical roots: Nrf2, helps regulate gene expression
by The Flippin Lyme Foundation
Research identifies key genetic link in the biology of aging
CORVALLIS, Ore. – New research at Oregon State University suggests it may be possible to slow age-related disease with new types of treatments.
Scientists have tracked the syndromes associated with aging to their biochemical roots, and identified a breakdown in genetic communication as part of the problem. The findings imply that aging happens for a reason, and that while aspects of it may be inevitable, there could be ways to slow down disease development.
The newest study relate to a protein, Nrf2, that helps regulate gene expression and the body’s reaction to various types of stressors. The research was published in Free Radical Biology and Medicine, in work supported by the National Institutes of Health and the Medical Research Foundation of Oregon.
“We’re very excited about the potential of this area of research,” said Tory Hagen, corresponding author on this study, and the Helen P. Rumbel Professor for Health Aging Research in the Linus Pauling Institute and the OSU Department of Biochemistry and Biophysics in the College of Science.
“At least one important part of what we call aging appears to be a breakdown in genetic communication, in which a regulator of stress resistance declines with age,” Hagen said. “As people age and their metabolic problems increase, the levels of this regulator, Nrf2, should be increasing, but in fact they are declining.”
Nrf2 is both a monitor and a messenger, OSU researchers say. It’s constantly on the lookout for problems with cells that may be caused by the many metabolic insults of life – oxidative stress, toxins, pollutants, and other metabolic dysfunction.
When it finds a problem, Nrf2 essentially goes back to the cellular nucleus and rings the alarm bell, where it can “turn on” up to 200 genes that are responsible for cell repair, detoxification of carcinogens, protein and lipid metabolism, antioxidant protection and other actions. In their report, the scientists called it a “longevity-assurance” factor.
Nrf2 is so important that it’s found in many life forms, not just humans, and it’s constantly manufactured by cells throughout the body. About half of it is used up every 20 minutes as it performs its life-protective functions. Metabolic insults routinely increase with age, and if things were working properly, the amount of Nrf2 that goes back into the nucleus should also increase to help deal with those insults.
Instead, the level of nuclear Nrf2 declines, and the OSU scientists say they have discovered why.
“The levels of Nrf2, and the functions associated with it, are routinely about 30-40 percent lower in older laboratory animals,” said Kate Shay, director of the Healthy Aging Core Laboratory at OSU and co-author on this study. “We’ve been able to show for the first time what we believe is the cause.”
The reason for this decline, the scientists said, is increasing levels of a micro-RNA called miRNA-146a.
Micro-RNAs have been one of the most profound scientific discoveries of the past 20 years. They were once thought to be “junk DNA” because researchers could see them but they had no apparent biological role. They are now understood to be anything but junk – they help play a major role in genetic signaling, controlling what genes are “expressed,” or turned on and off to perform their function.
In humans, miRNA-146a plays a significant role. It can turn on the inflammation processes that, in something like a wound, help prevent infection and begin the healing process. But with aging, this study now shows that miRNA-146a expression doesn’t shut down properly, and it can significantly reduce the levels of Nrf2.
This can cause part of the chronic, low-grade inflammation that is associated with the degenerative diseases that now kill most people in the developed world, including heart disease, cancer, diabetes and neurological disease.
“The action of miRNA-146a in older people appears to turn from a good to a bad influence,” Shay said. “It may be causing our detoxification processes to decline just when we need them the most.”
Some of the things found to be healthy for individuals, in diet or lifestyle, may be so because they help to conserve the proper balance between the actions of miRNA-146a and Nrf2, the OSU researchers said. Alternatively, it may be possible to reduce excessive levels of miRNA-146a with compounds that interfere with its function. There may also be other micro-RNAs associated with this process, they said, that need further research.
“Overall, these results provide novel insights for the age-related decline in Nrf2 and identify new targets to maintain Nrf2-dependent detoxification with age,” the researchers wrote in their conclusion.
Source location: http://nebula.wsimg.com/fca73d368ba03a877044b0e26d4a5557?AccessKeyId=87810FBC0BF20D362EFB&disposition=0&alloworigin=1